Leap Therapeutics, Inc. LPTX 深 滬
等待開盤 12-12 09:30:00 美东时间
2.05
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 2.05
- 總市值 8495.10万
- 52周最高 3.58
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.2223
- 委 比 0.00%
- 總股本 4143.95万
- 歷史最高 153.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.2223
- 每 手 1
- 風險率 0.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor
CAMBRIDGE, Mass., Dec. 9, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) today announced that industry pioneer Zooko Wilcox, the founder of Zcash, former CEO of the Electri...
12-09 20:00
Why Leap Therapeutics Stock (LPTX) Is in the News
U.S.-based Leap Therapeutics ($LPTX) shocked investors with a 368.6% surge in i...
11-14 04:45
What's Going On With Leap Therapeutics Stock On Thursday?
Leap Therapeutics shares are plunging after rebranding as Cypherpunk, pivoting to a Zcash treasury and announcing a $200M stock offering.
11-13 23:02
3 Penny Stocks to Watch Now, 11/13/25
Leap Therapeutics, Amaze Holdings, and Salarius Pharmaceuticals are the 3...
11-13 23:02
美股牛股 | BBAI涨超18%，分析师称收购Ask Sage将为2026年收入提供强劲助力；昂跑涨18%
BBAI涨超18%，分析师称收购Ask Sage将为2026年收入提供强劲助力；ONON涨18%，Q3净销售额7.94亿瑞士法郎高于预期，上调年度收入展望>>
11-13 14:54
Leap Therapeutics Enters $200M Equity Sales Agreement
Leap Therapeutics ( ($LPTX) ) just unveiled an update. On November 12, 2025, Cy...
11-13 05:43
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 176.6% to $1.21...
11-13 01:05
Cypherpunk Technologies GAAP EPS of -$0.08
Cypherpunk Technologies press release (LPTX): Q3 GAAP EPS of -$0.08. Cash and cash equivalents totaled $9.7 million on September 30, 2025, prior to the completion of the $58.88 million private placeme...
11-12 22:19
Leap Therapeutics shares are trading higher after the company reported better-than-expected Q3 EPS results.
Leap Therapeutics shares are trading higher after the company reported better-t...
11-12 22:18
Leap Therapeutics Q3 EPS $(0.08) Beats $(0.24) Estimate
Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.24) by 66.67 percent. This is a 81.82 percent increase over losses of $(0.44) per share from
11-12 21:15
